The L’Oréal Cell BioPoint, which was unveiled at CES 2025, utilizes advanced proteomics, which is the study of how protein composition in the human body affects skin aging.
Cencora has acquired an interest in RCA of approximately 85%, with certain RCA physicians and members of the management team retaining a minority equity interest in the company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback